Exhibitors Search
S&K THERAPEUTICS
Booth no.
E41
| Exhibition | PARTNERING |
|---|---|
| Country | Korea, South |
| Address | 199 World cup-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea |
| Tel (Rep.) | 031-212-2666 |
| Website | http://www.snktherapeutics.com |
Company Introduction
S&K Therapeutics is a biotechnology company developing innovative immunomodulatory medicines. Our AI-driven discovery platform and molecular docking simulations speed the identification and optimization of novel candidates. We focus on autoimmune and inflammatory diseases with a pipeline spanning small-molecule NLRP3 inhibitors, immunostimulatory aptamers, and growth factor?mimetic peptides. Robust translational systems combine biomarker strategies, preclinical validation, and scalable CMC to advance programs efficiently into clinical trials. We are building GMP-compliant quality frameworks and global regulatory pathways to enable commercialization. Our goal is to deliver precision medicines that improve outcomes and create lasting value for patients, clinicians, and partners worldwide.
Promotional video
Exhibit Item
Development of Precision Immunomodulatory Therapeutics Targeting Autoimmune and Inflammatory Diseases
Exhibit Item Images
-
Product Name : Precision Immunomodulatory Drug Development for Autoimmune and Inflammatory DiseasesS&K Therapeutics is developing precision drugs for autoimmune and inflammatory diseases. Our pipeline includes NLRP3 inhibitors, immunostimulatory aptamers, and growth factor?mimetic peptides, supported by AI discovery and molecular docking to speed development.
Exhibit Description
S&K Therapeutics develops precision medicines for autoimmune and inflammatory diseases. Our pipeline includes NLRP3 inhibitors, immunostimulatory aptamers, and growth factor?mimetic peptides, supported by AI-driven discovery to accelerate innovation and clinical progress.
Co-Exhibitor or
Partner’s Information
| Company Name | Country |
|---|---|
KYUNGYON EXHIBITION CORP.